{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:12:14Z","timestamp":1793329934896,"version":"4.5.0"},"reference-count":229,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222006"],"award-info":[{"award-number":["82222006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232094"],"award-info":[{"award-number":["7232094"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2022YFA1104800"],"award-info":[{"award-number":["2022YFA1104800"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jare.2025.01.001","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T10:55:56Z","timestamp":1737197756000},"page":"443-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["LMNA-related cardiomyopathy: From molecular pathology to cardiac gene therapy"],"prefix":"10.1016","volume":"77","author":[{"given":"Ze","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qirui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-4287","authenticated-orcid":false,"given":"Yifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6009-4403","authenticated-orcid":false,"given":"Yuxuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7644","key":"10.1016\/j.jare.2025.01.001_b0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nature21382","article-title":"The molecular architecture of lamins in somatic cells","volume":"543","author":"Turgay","year":"2017","journal-title":"Nature"},{"issue":"6088","key":"10.1016\/j.jare.2025.01.001_b0010","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/323560a0","article-title":"The nuclear lamina is a meshwork of intermediate-type filaments","volume":"323","author":"Aebi","year":"1986","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrm3488","article-title":"The nuclear lamins: flexibility in function","volume":"14","author":"Burke","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jare.2025.01.001_b0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-biochem-060614-034115","article-title":"Lamins: nuclear intermediate filament proteins with fundamental functions in nuclear mechanics and genome regulation","volume":"84","author":"Gruenbaum","year":"2015","journal-title":"Annu Rev Biochem"},{"issue":"10","key":"10.1016\/j.jare.2025.01.001_b0025","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1073\/pnas.1810070116","article-title":"Concentric organization of A- and B-type lamins predicts their distinct roles in the spatial organization and stability of the nuclear lamina","volume":"116","author":"Nmezi","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0030","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1742-4658.2007.05695.x","article-title":"Nucleoplasmic lamins and their interaction partners, LAP2alpha, Rb, and BAF, in transcriptional regulation","volume":"274","author":"Dorner","year":"2007","journal-title":"Febs j"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tcb.2013.11.004","article-title":"Broken nuclei\u2013lamins, nuclear mechanics, and disease","volume":"24","author":"Davidson","year":"2014","journal-title":"Trends Cell Biol"},{"issue":"7","key":"10.1016\/j.jare.2025.01.001_b0040","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1083\/jcb.200904124","article-title":"Role of A-type lamins in signaling, transcription, and chromatin organization","volume":"187","author":"Andr\u00e9s","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jare.2025.01.001_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2023.102313","article-title":"Lamins: the backbone of the nucleocytoskeleton interface","volume":"86","author":"Sobo","year":"2024","journal-title":"Curr Opin Cell Biol"},{"issue":"12","key":"10.1016\/j.jare.2025.01.001_b0050","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jacbts.2022.09.002","article-title":"New insights into the therapy forlamin-associated dilatedcardiomyopathy","volume":"7","author":"Zhang","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jare.2025.01.001_b0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-pathol-042220-034240","article-title":"Molecular pathology of laminopathies","volume":"17","author":"Shin","year":"2022","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10.1016\/j.jare.2025.01.001_b0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.101.5.473","article-title":"Lamin A\/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement","volume":"101","author":"Brodsky","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejheart.2005.08.007","article-title":"Severe dilated cardiomyopathy and quadriceps myopathy due to lamin A\/C gene mutation: a phenotypic study","volume":"8","author":"Charniot","year":"2006","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"10.1016\/j.jare.2025.01.001_b0070","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.ehj.2003.09.020","article-title":"Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A\/C gene mutations","volume":"24","author":"Sanna","year":"2003","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b0075","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jamacardio.2017.5235","article-title":"Cardiac abnormalities in patients with hutchinson-gilford progeria syndrome","volume":"3","author":"Prakash","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"23","key":"10.1016\/j.jare.2025.01.001_b0080","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1161\/CIRCULATIONAHA.123.064370","article-title":"Progression of cardiac abnormalities in hutchinson-gilford progeria syndrome: a prospective longitudinal study","volume":"147","author":"Olsen","year":"2023","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.jare.2025.01.001_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10215075","article-title":"Clinical features of LMNA-related cardiomyopathy in 18 patients and characterization of two novel variants","volume":"10","author":"Ferradini","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0090","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0735-1097(02)01724-2","article-title":"Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A\/C defect-related disease","volume":"39","author":"Arbustini","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jare.2025.01.001_b0095","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.jacc.2022.08.804","article-title":"Prognostic prediction of genotype vs phenotype in genetic cardiomyopathies","volume":"80","author":"Paldino","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jare.2025.01.001_b0100","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C Mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b0105","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004357","article-title":"Multicenter experience with catheter ablation for ventricular tachycardia in lamin A\/C cardiomyopathy","volume":"9","author":"Kumar","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"10","key":"10.1016\/j.jare.2025.01.001_b0110","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","article-title":"Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation","volume":"39","author":"Hasselberg","year":"2018","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jare.2025.01.001_b0115","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jare.2025.01.001_b0120","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehr451","article-title":"Mutations in the lamin A\/C gene mimic arrhythmogenic right ventricular cardiomyopathy","volume":"33","author":"Quarta","year":"2012","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0125","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jacc.2019.05.022","article-title":"Phenotypic manifestations of arrhythmogenic cardiomyopathy in children and adolescents","volume":"74","author":"DeWitt","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.jare.2025.01.001_b0130","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/eurheartj\/ehz172","article-title":"A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression","volume":"40","author":"Chen","year":"2019","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jare.2025.01.001_b0135","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jamacardio.2021.3370","article-title":"Early-onset atrial fibrillation and the prevalence of rare variants in cardiomyopathy and arrhythmia genes","volume":"6","author":"Yoneda","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"15","key":"10.1016\/j.jare.2025.01.001_b0140","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jare.2025.01.001_b0145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrcardio.2017.190","article-title":"Role of titin in cardiomyopathy: from DNA variants to patient stratification","volume":"15","author":"Ware","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b0155","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.673","article-title":"Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy","volume":"19","author":"Jansweijer","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.jare.2025.01.001_b0160","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011548","article-title":"REALM-DCM: a phase 3, multinational, randomized, placebo-controlled trial of ARRY-371797 in patients with symptomatic LMNA-related dilated cardiomyopathy","volume":"17","author":"Garcia-Pavia","year":"2024","journal-title":"Circ Heart Fail"},{"issue":"7","key":"10.1016\/j.jare.2025.01.001_b0165","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrm2197","article-title":"Intermediate filaments: from cell architecture to nanomechanics","volume":"8","author":"Herrmann","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jare.2025.01.001_b0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2022.06.038","article-title":"The LMNA p.R541C mutation causes dilated cardiomyopathy in human and mice","volume":"363","author":"Yang","year":"2022","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.jare.2025.01.001_b0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.21417","article-title":"De novo LMNA mutations cause a new form of congenital muscular dystrophy","volume":"64","author":"Quijano-Roy","year":"2008","journal-title":"Ann Neurol"},{"issue":"23","key":"10.1016\/j.jare.2025.01.001_b0180","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","article-title":"Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease","volume":"341","author":"Fatkin","year":"1999","journal-title":"N Engl J Med"},{"issue":"29","key":"10.1016\/j.jare.2025.01.001_b0185","doi-asserted-by":"crossref","first-page":"7689","DOI":"10.1073\/pnas.1707741114","article-title":"Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing","volume":"114","author":"Ito","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.jare.2025.01.001_b0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/CIRCGEN.119.002853","article-title":"LMNA missense mutation causes nonsense-mediated mRNA decay and severe dilated cardiomyopathy","volume":"13","author":"Kato","year":"2020","journal-title":"Circ Genom Precis Med"},{"issue":"7769","key":"10.1016\/j.jare.2025.01.001_b0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41586-019-1406-x","article-title":"Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy","volume":"572","author":"Lee","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jare.2025.01.001_b0200","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","article-title":"Quality and quantity control of gene expression by nonsense-mediated mRNA decay","volume":"20","author":"Kurosaki","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00395-010-0085-4","article-title":"Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A\/C gene is associated with cardiomyocyte nuclear envelope disruption","volume":"105","author":"Gupta","year":"2010","journal-title":"Basic Res Cardiol"},{"issue":"25","key":"10.1016\/j.jare.2025.01.001_b0210","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.jacc.2007.02.063","article-title":"Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A\/C gene","volume":"49","author":"van Tintelen","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.jare.2025.01.001_b0215","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCULATIONAHA.120.050432","article-title":"Genetic variation in enhancers modifies cardiomyopathy gene expression and progression","volume":"143","author":"Gacita","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0220","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1388-9842(03)00149-1","article-title":"Apical left ventricular aneurysm without atrio-ventricular block due to a lamin A\/C gene mutation","volume":"5","author":"Forissier","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0225","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00395-008-0748-6","article-title":"Identification of mutational hot spots in LMNA encoding lamin A\/C in patients with familial dilated cardiomyopathy","volume":"104","author":"Perrot","year":"2009","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.15420\/aer.2012.1.22","article-title":"What should the cardiologist know about lamin disease?","volume":"1","author":"Charron","year":"2012","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0235","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1042\/BST20110670","article-title":"Clinical and genetic heterogeneity in laminopathies","volume":"39","author":"Bertrand","year":"2011","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0240","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1038\/s41467-019-11684-x","article-title":"Structural basis for lamin assembly at the molecular level","volume":"10","author":"Ahn","year":"2019","journal-title":"Nat Commun"},{"issue":"20","key":"10.1016\/j.jare.2025.01.001_b0245","doi-asserted-by":"crossref","first-page":"17381","DOI":"10.1074\/jbc.C200038200","article-title":"Structure of the globular tail of nuclear lamin","volume":"277","author":"Dhe-Paganon","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41525-021-00265-x","article-title":"Most myopathic lamin variants aggregate: a functional genomics approach for assessing variants of uncertain significance","volume":"6","author":"Anderson","year":"2021","journal-title":"NPJ Genom Med"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCGENETICS.109.905422","article-title":"Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy","volume":"3","author":"Cowan","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jare.2025.01.001_b0260","doi-asserted-by":"crossref","unstructured":"Bhattacharjee P, Dasgupta D, Sengupta K. DCM associated LMNA mutations cause distortions in lamina structure and assembly. Biochim Biophys Acta Gen Subj. 2017;1861(11 Pt A):2598-608.","DOI":"10.1016\/j.bbagen.2017.08.016"},{"issue":"10","key":"10.1016\/j.jare.2025.01.001_b0265","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/ejhf.1241","article-title":"The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope","volume":"20","author":"Al-Saaidi","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.jare.2025.01.001_b0270","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0275","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001603","article-title":"Gene-based risk stratification for cardiac disorders in LMNA mutation carriers","volume":"10","author":"Nishiuchi","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jacc.2022.04.035","article-title":"LMNA variants and risk of adult-onset cardiac disease","volume":"80","author":"Lazarte","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010895","article-title":"Caenorhabditis elegans models for striated muscle disorders caused by missense variants of human LMNA","volume":"19","author":"Gregory","year":"2023","journal-title":"PLoS Genet"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081142","article-title":"Drosophila models reveal properties of mutant lamins that give rise to distinct diseases","volume":"12","author":"Walker","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b0295","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/dvdy.427","article-title":"A CRISPR\/Cas9 zebrafish lamin A\/C mutant model of muscular laminopathy","volume":"251","author":"Nicolas","year":"2022","journal-title":"Dev Dyn"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0300","doi-asserted-by":"crossref","first-page":"12826","DOI":"10.1038\/s41598-024-63711-7","article-title":"Creatine and L-carnitine attenuate muscular laminopathy in the LMNA mutation transgenic zebrafish","volume":"14","author":"Pan","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0305","doi-asserted-by":"crossref","first-page":"102","DOI":"10.14336\/AD.2018.0209","article-title":"LMNA-mutated rabbits: a model of premature aging syndrome with muscular dystrophy and dilated cardiomyopathy","volume":"10","author":"Sui","year":"2019","journal-title":"Aging Dis"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0310","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jacbts.2023.11.002","article-title":"Primate model carrying LMNA mutation develops dilated cardiomyopathy","volume":"9","author":"Luo","year":"2024","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0315","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/hmg\/ddi017","article-title":"Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies","volume":"14","author":"Arimura","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"15","key":"10.1016\/j.jare.2025.01.001_b0320","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/hmg\/ddi221","article-title":"Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice","volume":"14","author":"Mounkes","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.jare.2025.01.001_b0325","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J","article-title":"Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A\/C gene","volume":"48","author":"Bonne","year":"2000","journal-title":"Ann Neurol"},{"issue":"15","key":"10.1016\/j.jare.2025.01.001_b0330","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/hmg\/ddt172","article-title":"Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity","volume":"22","author":"Cattin","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.jare.2025.01.001_b0335","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/hmg\/ddr534","article-title":"DelK32-lamin A\/C has abnormal location and induces incomplete tissue maturation and severe metabolic defects leading to premature death","volume":"21","author":"Bertrand","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b0340","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jmb.2004.08.093","article-title":"Crystal structure of the human lamin A coil 2B dimer: implications for the head-to-tail association of nuclear lamins","volume":"343","author":"Strelkov","year":"2004","journal-title":"J Mol Biol"},{"issue":"16","key":"10.1016\/j.jare.2025.01.001_b0345","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/hmg\/ddl170","article-title":"Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy","volume":"15","author":"Wang","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.jare.2025.01.001_b0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015167","article-title":"LMNA E82K mutation activates FAS and mitochondrial pathways of apoptosis in heart tissue specific transgenic mice","volume":"5","author":"Lu","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0355","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/CIRCRESAHA.118.314238","article-title":"DNA damage response\/TP53 pathway is activated and contributes to the pathogenesis of dilated cardiomyopathy associated with LMNA (Lamin A\/C) mutations","volume":"124","author":"Chen","year":"2019","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.jare.2025.01.001_b0360","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/1346-8138.12657","article-title":"First Japanese case of atypical progeroid syndrome\/atypical Werner syndrome with heterozygous LMNA mutation","volume":"41","author":"Motegi","year":"2014","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0365","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.RES.0000065442.64694.9F","article-title":"Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter","volume":"92","author":"Sanbe","year":"2003","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.jare.2025.01.001_b0370","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1083\/jcb.147.5.913","article-title":"Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy","volume":"147","author":"Sullivan","year":"1999","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0375","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI200419448","article-title":"Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A\/C-deficient mice","volume":"113","author":"Nikolova","year":"2004","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jare.2025.01.001_b0380","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.yjmcc.2007.11.008","article-title":"Lamin A\/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease","volume":"44","author":"Wolf","year":"2008","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0385","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.yjmcc.2009.10.024","article-title":"Attenuated hypertrophic response to pressure overload in a lamin A\/C haploinsufficiency mouse","volume":"48","author":"Cupesi","year":"2010","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"10.1016\/j.jare.2025.01.001_b0390","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4161\/nucl.21676","article-title":"A truncated lamin A in the Lmna -\/- mouse line: implications for the understanding of laminopathies","volume":"3","author":"Jahn","year":"2012","journal-title":"Nucleus"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0395","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4161\/nucl.2.3.15731","article-title":"Post-natal myogenic and adipogenic developmental: defects and metabolic impairment upon loss of A-type lamins","volume":"2","author":"Kubben","year":"2011","journal-title":"Nucleus"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0400","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbrc.2013.08.082","article-title":"Generation and characterization of a conditional deletion allele for Lmna in mice","volume":"440","author":"Kim","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0405","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.1038\/s41467-022-34366-7","article-title":"Lamin A\/C-dependent chromatin architecture safeguards na\u00efve pluripotency to prevent aberrant cardiovascular cell fate and function","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.jare.2025.01.001_b0410","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1172\/JCI135922","article-title":"BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A\/C-deficient mice","volume":"130","author":"Auguste","year":"2020","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.jare.2025.01.001_b0415","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCRESAHA.119.314794","article-title":"Suppresses dilated cardiomyopathy and cardiac fibrosis through regulation of Bmp7 and Ctgf","volume":"125","author":"Tan","year":"2019","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.jare.2025.01.001_b0420","first-page":"1308","article-title":"Non-cell-autonomous cardiomyocyte regulation complicates gene supplementation therapy for <i>Lmna<\/i>-associated cardiac defects in","volume":"9","author":"Sun","year":"2024","journal-title":"Mice"},{"key":"10.1016\/j.jare.2025.01.001_b0425","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2019.09.058","article-title":"Expression of Lmna-R225X nonsense mutation results in dilated cardiomyopathy and conduction disorders (DCM-CD) in mice: Impact of exercise training","volume":"298","author":"Cai","year":"2020","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.jare.2025.01.001_b0430","doi-asserted-by":"crossref","first-page":"803","DOI":"10.18632\/aging.100503","article-title":"Modeling of lamin A\/C mutation premature cardiac aging using patient\u2010specific induced pluripotent stem cells","volume":"4","author":"Siu","year":"2012","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0435","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","article-title":"Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery-Dreifuss muscular dystrophy","volume":"21","author":"Bonne","year":"1999","journal-title":"Nat Genet"},{"issue":"6937","key":"10.1016\/j.jare.2025.01.001_b0440","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature01631","article-title":"A progeroid syndrome in mice is caused by defects in A-type lamins","volume":"423","author":"Mounkes","year":"2003","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jare.2025.01.001_b0445","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0450","doi-asserted-by":"crossref","DOI":"10.1172\/JCI136488","article-title":"Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy","volume":"131","author":"Gu\u00e9nantin","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0455","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/s41467-019-09929-w","article-title":"The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy","volume":"10","author":"Salvarani","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.01.001_b0460","doi-asserted-by":"crossref","unstructured":"Shah PP, Lv W, Rhoades JH, Poleshko A, Abbey D, Caporizzo MA, et al. Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes. Cell stem cell. 2021;28(5):938-54.e9.","DOI":"10.1016\/j.stem.2020.12.016"},{"issue":"9","key":"10.1016\/j.jare.2025.01.001_b0465","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1083\/jcb.201902117","article-title":"Chromatin compartment dynamics in a haploinsufficient model of cardiac laminopathy","volume":"218","author":"Bertero","year":"2019","journal-title":"J Cell Biol"},{"issue":"15","key":"10.1016\/j.jare.2025.01.001_b0470","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22157874","article-title":"Investigating LMNA-related dilated cardiomyopathy using human induced pluripotent stem cell-derived cardiomyocytes","volume":"22","author":"Shemer","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0475","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060594","article-title":"Modeling of LMNA-related dilated cardiomyopathy using human induced pluripotent stem cells","volume":"8","author":"Shah","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0480","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1038\/s41467-024-51318-5","article-title":"Lamin A\/C deficiency-mediated ROS elevation contributes to pathogenic phenotypes of dilated cardiomyopathy in iPSC model","volume":"15","author":"Qiu","year":"2024","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b0485","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005677","article-title":"Modeling treatment response for Lamin A\/C related dilated cardiomyopathy in human induced pluripotent stem cells","volume":"6","author":"Lee","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.jare.2025.01.001_b0490","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/CIRCRESAHA.116.309727","article-title":"Gene editing with CRISPR\/Cas9 RNA-directed nuclease","volume":"120","author":"Doetschman","year":"2017","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.jare.2025.01.001_b0495","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.stem.2010.12.008","article-title":"Stage-specific optimization of activin\/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines","volume":"8","author":"Kattman","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b0500","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nmeth902","article-title":"Feeder-independent culture of human embryonic stem cells","volume":"3","author":"Ludwig","year":"2006","journal-title":"Nat Methods"},{"issue":"5","key":"10.1016\/j.jare.2025.01.001_b0505","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nmeth.1593","article-title":"Chemically defined conditions for human iPSC derivation and culture","volume":"8","author":"Chen","year":"2011","journal-title":"Nat Methods"},{"issue":"27","key":"10.1016\/j.jare.2025.01.001_b0510","doi-asserted-by":"crossref","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","article-title":"Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling","volume":"109","author":"Lian","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b0515","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nat Methods"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b0520","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cmet.2016.03.001","article-title":"Glutamine oxidation is indispensable for survival of human pluripotent stem cells","volume":"23","author":"Tohyama","year":"2016","journal-title":"Cell Metab"},{"issue":"554","key":"10.1016\/j.jare.2025.01.001_b0525","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax9276","article-title":"Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy","volume":"12","author":"Sayed","year":"2020","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0530","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2010.12.002","article-title":"A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects","volume":"8","author":"Zhang","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jare.2025.01.001_b0535","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.778982","article-title":"Phenotypic variability in iPSC-induced cardiomyocytes and cardiac fibroblasts carrying diverse LMNA mutations","volume":"12","author":"Yang","year":"2021","journal-title":"Front Physiol"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b0540","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/CIRCRESAHA.119.315862","article-title":"Cardiomyocyte maturation: new phase in development","volume":"126","author":"Guo","year":"2020","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0545","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41421-022-00446-7","article-title":"Generation of high-performance human cardiomyocytes and engineered heart tissues from extended pluripotent stem cells","volume":"8","author":"Li","year":"2022","journal-title":"Cell Discov"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0550","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCRESAHA.109.211458","article-title":"Development of a drug screening platform based on engineered heart tissue","volume":"107","author":"Hansen","year":"2010","journal-title":"Circ Res"},{"issue":"9\u201310","key":"10.1016\/j.jare.2025.01.001_b0555","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1089\/ten.tea.2011.0341","article-title":"A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues","volume":"18","author":"Boudou","year":"2012","journal-title":"Tissue Eng Part A"},{"issue":"20","key":"10.1016\/j.jare.2025.01.001_b0560","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.114.014998","article-title":"Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue","volume":"134","author":"Ruan","year":"2016","journal-title":"Circulation"},{"issue":"7700","key":"10.1016\/j.jare.2025.01.001_b0565","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","article-title":"Advanced maturation of human cardiac tissue grown from pluripotent stem cells","volume":"556","author":"Ronaldson-Bouchard","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.01.001_b0570","doi-asserted-by":"crossref","unstructured":"Hofbauer P, Jahnel SM, Papai N, Giesshammer M, Deyett A, Schmidt C, et al. Cardioids reveal self-organizing principles of human cardiogenesis. Cell. 2021;184(12):3299-317.e22.","DOI":"10.1016\/j.cell.2021.04.034"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0575","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41587-021-00815-9","article-title":"Human heart-forming organoids recapitulate early heart and foregut development","volume":"39","author":"Drakhlis","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2025.01.001_b0580","doi-asserted-by":"crossref","unstructured":"Schmidt C, Deyett A, Ilmer T, Haendeler S, Torres Caballero A, Novatchkova M, et al. Multi-chamber cardioids unravel human heart development and cardiac defects. Cell. 2023;186(25):5587-605.e27.","DOI":"10.1016\/j.cell.2023.10.030"},{"key":"10.1016\/j.jare.2025.01.001_b0585","doi-asserted-by":"crossref","unstructured":"Li J, Wiesinger A, Fokkert L, Bakker P, de Vries DK, Tijsen AJ, et al. Modeling the atrioventricular conduction axis using human pluripotent stem cell-derived cardiac assembloids. Cell stem cell. 2024;31(11):1667-84.e6.","DOI":"10.1016\/j.stem.2024.08.008"},{"issue":"21","key":"10.1016\/j.jare.2025.01.001_b0590","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/hmg\/ddh295","article-title":"Decreased mechanical stiffness in LMNA-\/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies","volume":"13","author":"Broers","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"6149","key":"10.1016\/j.jare.2025.01.001_b0595","doi-asserted-by":"crossref","DOI":"10.1126\/science.1240104","article-title":"Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation","volume":"341","author":"Swift","year":"2013","journal-title":"Science (New York, NY)"},{"issue":"Pt 20","key":"10.1016\/j.jare.2025.01.001_b0600","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1242\/jcs.01357","article-title":"The nuclear envelope lamina network has elasticity and a compressibility limit suggestive of a molecular shock absorber","volume":"117","author":"Dahl","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jare.2025.01.001_b0605","doi-asserted-by":"crossref","unstructured":"Antoku S, Wu W, Joseph LC, Morrow JP, Worman HJ, Gundersen GG. ERK1\/2 Phosphorylation of FHOD Connects Signaling and Nuclear Positioning Alternations in Cardiac Laminopathy. Dev Cell. 2019;51(5):602-16.e12.","DOI":"10.1016\/j.devcel.2019.10.023"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114284","article-title":"Pervasive nuclear envelope ruptures precede ECM signaling and disease onset without activating cGAS-STING in Lamin-cardiomyopathy mice","volume":"43","author":"En","year":"2024","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b0615","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41563-019-0563-5","article-title":"Mutant lamins cause nuclear envelope rupture and DNA damage in skeletal muscle cells","volume":"19","author":"Earle","year":"2020","journal-title":"Nat Mater"},{"key":"10.1016\/j.jare.2025.01.001_b0620","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yjmcc.2018.10.017","article-title":"Amelioration of desmin network defects by \u03b1B-crystallin overexpression confers cardioprotection in a mouse model of dilated cardiomyopathy caused by LMNA gene mutation","volume":"125","author":"Galata","year":"2018","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0625","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/CIRCRESAHA.114.301236","article-title":"Linker of nucleoskeleton and cytoskeleton complex proteins in cardiac structure, function, and disease","volume":"114","author":"Stroud","year":"2014","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0630","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cell.2012.01.059","article-title":"Accumulation of the inner nuclear envelope protein Sun1 is pathogenic in progeric and dystrophic laminopathies","volume":"149","author":"Chen","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0635","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1038\/s41467-021-24849-4","article-title":"Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy","volume":"12","author":"Chai","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0640","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1186\/s12967-023-04542-4","article-title":"Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity","volume":"21","author":"Tan","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.jare.2025.01.001_b0645","doi-asserted-by":"crossref","unstructured":"Cho S, Vashisth M, Abbas A, Majkut S, Vogel K, Xia Y, et al. Mechanosensing by the lamina protects against nuclear rupture, DNA damage, and cell-cycle arrest. Dev Cell. 2019;49(6):920-35.e5.","DOI":"10.1016\/j.devcel.2019.04.020"},{"issue":"9","key":"10.1016\/j.jare.2025.01.001_b0650","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.jare.2025.01.001_b0655","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jacbts.2022.06.015","article-title":"Genetic ablation of the DNA damage response pathway attenuates lamin-associated dilated cardiomyopathy in mice","volume":"7","author":"Cheedipudi","year":"2022","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0660","doi-asserted-by":"crossref","first-page":"28","DOI":"10.18632\/aging.100012","article-title":"Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A","volume":"1","author":"Musich","year":"2009","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.jare.2025.01.001_b0665","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.molcel.2016.06.034","article-title":"DNA breaks and end resection measured genome-wide by end sequencing","volume":"63","author":"Canela","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.jare.2025.01.001_b0670","article-title":"DNA double-stranded breaks, a hallmark of aging, defined at the nucleotide resolution, are increased and associated with transcription in the cardiac myocytes in LMNA-cardiomyopathy","author":"Cathcart","year":"2024","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0675","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41420-024-01998-1","article-title":"Eliminating elevated p53 signaling fails to rescue skeletal muscle defects or extend survival in lamin A\/C-deficient mice","volume":"10","author":"Kirby","year":"2024","journal-title":"Cell Death Discovery"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b0680","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s43587-022-00261-5","article-title":"Somatic mutations in single human cardiomyocytes reveal age-associated DNA damage and widespread oxidative genotoxicity","volume":"2","author":"Choudhury","year":"2022","journal-title":"Nat Aging"},{"key":"10.1016\/j.jare.2025.01.001_b0685","doi-asserted-by":"crossref","unstructured":"Reichart D, Lindberg EL, Maatz H, Miranda AMA, Viveiros A, Shvetsov N, et al. Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies. Science (New York, NY). 2022;377(6606):eabo1984.","DOI":"10.1093\/eurheartj\/ehac544.2992"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b0690","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.118.314177","article-title":"Genomic reorganization of lamin-associated domains in cardiac myocytes is associated with differential gene expression and DNA methylation in human dilated cardiomyopathy","volume":"124","author":"Cheedipudi","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jare.2025.01.001_b0695","doi-asserted-by":"crossref","unstructured":"Kubo N, Chen PB, Hu R, Ye Z, Sasaki H, Ren B. H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation. Mol Cell. 2024;84(9):1742-52.e5.","DOI":"10.1016\/j.molcel.2024.02.030"},{"key":"10.1016\/j.jare.2025.01.001_b0700","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semcdb.2013.12.008","article-title":"Emerin in health and disease","volume":"29","author":"Koch","year":"2014","journal-title":"Semin Cell Dev Biol"},{"issue":"7450","key":"10.1016\/j.jare.2025.01.001_b0705","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature12105","article-title":"Lamin A\/C and emerin regulate MKL1-SRF activity by modulating actin dynamics","volume":"497","author":"Ho","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b0710","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1091\/mbc.e13-11-0644","article-title":"Concentration-dependent lamin assembly and its roles in the localization of other nuclear proteins","volume":"25","author":"Guo","year":"2014","journal-title":"Mol Biol Cell"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0715","doi-asserted-by":"crossref","first-page":"7886","DOI":"10.1038\/s41467-022-35639-x","article-title":"Actin-microtubule cytoskeletal interplay mediated by MRTF-A\/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations","volume":"13","author":"Le Dour","year":"2022","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.jare.2025.01.001_b0720","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s11427-023-2385-x","article-title":"A shared role of the myocardin-family transcriptional coactivators in cardiomyocyte maturation","volume":"66","author":"Guo","year":"2023","journal-title":"Sci China Life Sci"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0725","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1038\/s41467-018-06347-2","article-title":"Hierarchical and stage-specific regulation of murine cardiomyocyte maturation by serum response factor","volume":"9","author":"Guo","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.jare.2025.01.001_b0730","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2008861118","article-title":"Sarcomeres regulate murine cardiomyocyte maturation through MRTF-SRF signaling","volume":"118","author":"Guo","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 13","key":"10.1016\/j.jare.2025.01.001_b0735","first-page":"2873","article-title":"Cellular microenvironments reveal defective mechanosensing responses and elevated YAP signaling in LMNA-mutated muscle precursors","volume":"127","author":"Bertrand","year":"2014","journal-title":"J Cell Sci"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0740","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4161\/cc.24061","article-title":"Resveratrol activates SIRT1 in a Lamin A-dependent manner","volume":"12","author":"Ghosh","year":"2013","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0745","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/jacs.0c10836","article-title":"A SIRT1 activator, Ginsenoside Rc, promotes energy metabolism in cardiomyocytes and neurons","volume":"143","author":"Huang","year":"2021","journal-title":"J Am Chem Soc"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0750","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cmet.2012.11.007","article-title":"Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria","volume":"16","author":"Liu","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.01.001_b0755","article-title":"SIRT1 ameliorates lamin A\/C deficiency-induced cardiac dysfunctionby promoting mitochondrialbioenergetics","author":"Du","year":"2024","journal-title":"JACC: Basic to Translational Science"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0760","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41392-023-01647-6","article-title":"Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.jare.2025.01.001_b0765","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCULATIONAHA.124.069972","article-title":"LMNA Q353R mutation causes dilated cardiomyopathy through impaired vitamin D signaling","volume":"150","author":"Ito","year":"2024","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jare.2025.01.001_b0770","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1172\/JCI29042","article-title":"Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy","volume":"117","author":"Muchir","year":"2007","journal-title":"J Clin Invest"},{"issue":"19","key":"10.1016\/j.jare.2025.01.001_b0775","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1093\/hmg\/dds265","article-title":"Abnormal p38\u03b1 mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A\/C gene mutation","volume":"21","author":"Muchir","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0780","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/CIRCULATIONAHA.110.970673","article-title":"Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A\/C gene","volume":"123","author":"Wu","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0785","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/cvr\/cvy040","article-title":"Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins","volume":"114","author":"Laurini","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.jare.2025.01.001_b0790","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/hmg\/ddn343","article-title":"Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins","volume":"18","author":"Muchir","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0795","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.bmc.2016.12.014","article-title":"Macrocyclic MEK1\/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A\/C gene mutation","volume":"25","author":"Wu","year":"2017","journal-title":"Bioorg Med Chem"},{"issue":"7\u20138","key":"10.1016\/j.jare.2025.01.001_b0800","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbadis.2010.04.001","article-title":"Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene","volume":"1802","author":"Wu","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"10.1016\/j.jare.2025.01.001_b0805","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1158\/1078-0432.CCR-20-5032","article-title":"FDA approval summary: selumetinib for plexiform neurofibroma","volume":"27","author":"Casey","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.jare.2025.01.001_b0810","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/cvr\/cvr301","article-title":"Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A\/C gene","volume":"93","author":"Muchir","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jare.2025.01.001_b0815","doi-asserted-by":"crossref","unstructured":"Choi JC, Muchir A, Wu W, Iwata S, Homma S, Morrow JP, et al. Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A\/C gene mutation. Sci Transl Med. 2012;4(144):144ra02.","DOI":"10.1126\/scitranslmed.3003875"},{"key":"10.1016\/j.jare.2025.01.001_b0820","doi-asserted-by":"crossref","unstructured":"Ramos FJ, Chen SC, Garelick MG, Dai DF, Liao CY, Schreiber KH, et al. Rapamycin reverses elevated mTORC1 signaling in lamin A\/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci Transl Med. 2012;4(144):144ra03.","DOI":"10.1126\/scitranslmed.3003802"},{"issue":"7","key":"10.1016\/j.jare.2025.01.001_b0825","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12071149","article-title":"Personalized medicine approach in a DCM patient with LMNA mutation reveals dysregulation of mTOR signaling","volume":"12","author":"Neupane","year":"2022","journal-title":"J Pers Med"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0830","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4161\/auto.8901","article-title":"Autophagic degradation of nuclear components in mammalian cells","volume":"5","author":"Park","year":"2009","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b0835","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011110","article-title":"mTOR inhibition prolongs survival and has beneficial effects on heart function after onset of lamin A\/C gene mutation cardiomyopathy in mice","volume":"17","author":"Wu","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jare.2025.01.001_b0840","doi-asserted-by":"crossref","first-page":"17039","DOI":"10.1038\/celldisc.2017.39","article-title":"Evidence that S6K1, but not 4E-BP1, mediates skeletal muscle pathology associated with loss of A-type lamins","volume":"3","author":"Liao","year":"2017","journal-title":"Cell Discov"},{"issue":"23","key":"10.1016\/j.jare.2025.01.001_b0845","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/hmg\/ddm238","article-title":"Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity","volume":"16","author":"Zhang","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0850","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41431-018-0294-0","article-title":"Assessment of fibroblast nuclear morphology aids interpretation of LMNA variants","volume":"27","author":"van Tienen","year":"2019","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0855","doi-asserted-by":"crossref","DOI":"10.20517\/jca.2022.14","article-title":"Deletion of the Lmna gene in fibroblasts causes senescence-associated dilated cardiomyopathy by activating the double-stranded DNA damage response and induction of senescence-associated secretory phenotype","volume":"2","author":"Rouhi","year":"2022","journal-title":"J Cardiovasc Aging"},{"issue":"9","key":"10.1016\/j.jare.2025.01.001_b0860","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/ATVBAHA.113.301933","article-title":"Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction","volume":"33","author":"Bidault","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.jare.2025.01.001_b0865","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/ATVBAHA.110.209460","article-title":"Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging","volume":"30","author":"Olive","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jare.2025.01.001_b0870","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.amjcard.2022.08.001","article-title":"Long-term efficacy and safety of ARRY-371797 (PF-07265803) in patients with Lamin A\/C-related dilated cardiomyopathy","volume":"183","author":"Judge","year":"2022","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0875","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.122.003730","article-title":"Efficacy and safety of ARRY-371797 in LMNA-related dilated cardiomyopathy: a phase 2 study","volume":"16","author":"MacRae","year":"2023","journal-title":"Circ Genom Precis Med"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0880","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41392-024-02035-4","article-title":"Nucleic acid drugs: recent progress and future perspectives","volume":"9","author":"Sun","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"6382","key":"10.1016\/j.jare.2025.01.001_b0885","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science (New York, NY)"},{"issue":"12","key":"10.1016\/j.jare.2025.01.001_b0890","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"issue":"23","key":"10.1016\/j.jare.2025.01.001_b0895","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa2412309","article-title":"CRISPR-Cas9 gene editing with nexiguran ziclumeran for ATTR cardiomyopathy","volume":"391","author":"Fontana","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0900","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"10416","key":"10.1016\/j.jare.2025.01.001_b0905","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126-1","article-title":"CAR T-cell therapy in autoimmune diseases","volume":"402","author":"Schett","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"7774","key":"10.1016\/j.jare.2025.01.001_b0910","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0915","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0920","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1038\/s41467-021-25439-0","article-title":"Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy","volume":"12","author":"Grote Beverborg","year":"2021","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.jare.2025.01.001_b0925","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/CIRCULATIONAHA.123.068111","article-title":"Antisense oligonucleotide therapy for calmodulinopathy","volume":"150","author":"Bortolin","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b0930","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1172\/JCI85908","article-title":"Modulation of LMNA splicing as a strategy to treat prelamin A diseases","volume":"126","author":"Lee","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2025.01.001_b0935","doi-asserted-by":"crossref","unstructured":"Tabebordbar M, Lagerborg KA, Stanton A, King EM, Ye S, Tellez L, et al. Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell. 2021;184(19):4919-38.e22.","DOI":"10.1016\/j.cell.2021.08.028"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0940","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gt.2010.105","article-title":"Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution","volume":"18","author":"Prasad","year":"2011","journal-title":"Gene Ther"},{"issue":"22","key":"10.1016\/j.jare.2025.01.001_b0945","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/CIRCULATIONAHA.123.065438","article-title":"MicroRNA-122-mediated liver detargeting enhances the tissue specificity of cardiac genome editing","volume":"149","author":"Yang","year":"2024","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jare.2025.01.001_b0950","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41569-020-00499-9","article-title":"Targeted delivery of therapeutic agents to the heart","volume":"18","author":"Sahoo","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"22","key":"10.1016\/j.jare.2025.01.001_b0955","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126315","article-title":"Prelamin A mediates myocardial inflammation in dilated and HIV-associated cardiomyopathies","volume":"4","author":"Brayson","year":"2019","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b0960","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1172\/JCI27125","article-title":"Prelamin A and lamin A appear to be dispensable in the nuclear lamina","volume":"116","author":"Fong","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2025.01.001_b0965","article-title":"Non-Cell-Autonomous Cardiomyocyte regulation complicates gene supplementation therapy for LMNA-associated cardiac defects in mice. JACC: basic to translational","author":"Sun","year":"2024","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jare.2025.01.001_b0970","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41589-024-01645-x","article-title":"The realization of CRISPR gene therapy","volume":"20","author":"Ma","year":"2024","journal-title":"Nat Chem Biol"},{"issue":"10","key":"10.1016\/j.jare.2025.01.001_b0975","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/CIRCULATIONAHA.120.052383","article-title":"Efficient in vivo homology-directed repair within cardiomyocytes","volume":"145","author":"Zheng","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0980","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1038\/s41467-021-26518-y","article-title":"Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo","volume":"12","author":"Ibraheim","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.01.001_b0985","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1143157","article-title":"Off-target effects in CRISPR\/Cas9 gene editing","volume":"11","author":"Guo","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b0990","doi-asserted-by":"crossref","DOI":"10.36922\/gtm.232","article-title":"Adenine base editing as a promising therapy for cardiovascular diseases","volume":"2","author":"Yang","year":"2023","journal-title":"GTM"},{"issue":"7603","key":"10.1016\/j.jare.2025.01.001_b0995","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"7681","key":"10.1016\/j.jare.2025.01.001_b1000","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b1005","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1038\/s41467-022-30800-y","article-title":"Transient expression of an adenine base editor corrects the Hutchinson-Gilford progeria syndrome mutation and improves the skin phenotype in mice","volume":"13","author":"Whisenant","year":"2022","journal-title":"Nat Commun"},{"issue":"7843","key":"10.1016\/j.jare.2025.01.001_b1010","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","article-title":"In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice","volume":"589","author":"Koblan","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b1015","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18145","article-title":"Adenine base editor-based correction of the cardiac pathogenic Lmna c.1621C\u2009>\u2009T mutation in murine hearts","volume":"28","author":"Yang","year":"2024","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.jare.2025.01.001_b1020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-022-02176-5","article-title":"Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice","volume":"29","author":"Chai","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b1025","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1038\/s41467-023-39352-1","article-title":"Striated muscle-specific base editing enables correction of mutations causing dilated cardiomyopathy","volume":"14","author":"Grosch","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.01.001_b1030","doi-asserted-by":"crossref","unstructured":"Nishiyama T, Zhang Y, Cui M, Li H, Sanchez-Ortiz E, McAnally JR, et al. Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy. Sci Transl Med. 2022;14(672):eade1633.","DOI":"10.1126\/scitranslmed.ade1633"},{"issue":"2","key":"10.1016\/j.jare.2025.01.001_b1035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41591-022-02190-7","article-title":"Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice","volume":"29","author":"Reichart","year":"2023","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b1040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41422-024-00930-7","article-title":"Base editing effectively prevents early-onset severe cardiomyopathy in Mybpc3 mutant mice","volume":"34","author":"Wu","year":"2024","journal-title":"Cell Res"},{"issue":"6628","key":"10.1016\/j.jare.2025.01.001_b1045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.ade1105","article-title":"Ablation of CaMKII\u03b4 oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease","volume":"379","author":"Lebek","year":"2023","journal-title":"Science (New York, NY)"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b1050","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175164","article-title":"CRISPR-Cas9 base editing of pathogenic CaMKII\u03b4 improves cardiac function in a humanized mouse model","volume":"134","author":"Lebek","year":"2024","journal-title":"J Clin Invest"},{"issue":"19","key":"10.1016\/j.jare.2025.01.001_b1055","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/CIRCULATIONAHA.123.065117","article-title":"Elimination of CaMKII\u03b4 autophosphorylation by CRISPR-Cas9 Base editing improves survival and cardiac function in heart failure in mice","volume":"148","author":"Lebek","year":"2023","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b1060","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41587-024-02320-1","article-title":"Epigenome editing technologies for discovery and medicine","volume":"42","author":"McCutcheon","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"16","key":"10.1016\/j.jare.2025.01.001_b1065","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.123.063972","article-title":"CRISPR activation reverses haploinsufficiency and functional deficits caused by TTN truncation variants","volume":"149","author":"Ghahremani","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jare.2025.01.001_b1070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/CIRCULATIONAHA.123.067890","article-title":"Allele-specific suppression of variant MHC with high-precision RNA nuclease CRISPR-Cas13d prevents hypertrophic cardiomyopathy","volume":"150","author":"Yang","year":"2024","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jare.2025.01.001_b1075","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41587-019-0178-z","article-title":"Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs","volume":"37","author":"Qu","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"11","key":"10.1016\/j.jare.2025.01.001_b1080","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41587-023-01927-0","article-title":"Precision RNA base editing with engineered and endogenous effectors","volume":"41","author":"Pfeiffer","year":"2023","journal-title":"Nat Biotechnol"},{"issue":"7785","key":"10.1016\/j.jare.2025.01.001_b1085","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jare.2025.01.001_b1090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41587-023-01758-z","article-title":"Efficient prime editing in mouse brain, liver and heart with dual AAVs","volume":"42","author":"Davis","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"7631","key":"10.1016\/j.jare.2025.01.001_b1095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"issue":"8021","key":"10.1016\/j.jare.2025.01.001_b1100","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-024-07613-8","article-title":"Transposase-assisted target-site integration for efficient plant genome engineering","volume":"631","author":"Liu","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b1105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41587-023-01748-1","article-title":"Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases","volume":"42","author":"Lampe","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b1110","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1038\/s41467-020-19230-w","article-title":"Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants","volume":"11","author":"Weinmann","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b1115","doi-asserted-by":"crossref","first-page":"10450","DOI":"10.1038\/s41467-024-54635-x","article-title":"AAV delivery strategy with mechanical support for safe and efficacious cardiac gene transfer in swine","volume":"15","author":"Mazurek","year":"2024","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.jare.2025.01.001_b1120","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","article-title":"Lethal immunotoxicity in high-dose systemic AAV therapy","volume":"31","author":"Duan","year":"2023","journal-title":"Molecular Therapy : the Journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.jare.2025.01.001_b1125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jare.2025.01.001_b1130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum Gene Ther"},{"issue":"8","key":"10.1016\/j.jare.2025.01.001_b1135","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.ymthe.2020.07.009","article-title":"Broader implications of progressive liver dysfunction and lethal sepsis in two boys following systemic high-dose AAV","volume":"28","author":"Morales","year":"2020","journal-title":"Molecular Therapy : The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.jare.2025.01.001_b1140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660302","article-title":"Answered and unanswered questions in early-stage viral vector transduction biology and innate primary cell toxicity for ex-vivo gene editing","volume":"12","author":"Dudek","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jare.2025.01.001_b1145","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1038\/s41467-021-26830-7","article-title":"Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models","volume":"12","author":"Hakim","year":"2021","journal-title":"Nat Commun"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:39:08Z","timestamp":1763771948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":229,"alternative-id":["S2090123225000013"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.01.001","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LMNA-related cardiomyopathy: From molecular pathology to cardiac gene therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}